Yakira Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-73,829
Closed -$3.02M 304
2024
Q2
$3.02M Buy
73,829
+45,496
+161% +$1.86M 1.1% 28
2024
Q1
$1.2M Buy
28,333
+13,333
+89% +$564K 0.36% 71
2023
Q4
$636K Buy
+15,000
New +$636K 0.21% 94